Annals
Established in 1927 by the American College of Physicians
:
Advanced search
 
box Article
 arrow  Table of Contents                
space
 arrow  Full Text of this article
space
 arrow  PDF of this article
(PDFs free after 6 months)
space
 arrow  Figures/Tables List
space
box Services
 arrow  Send comment/rapid response letter
space
 arrow  Notify a friend about this article
space
 arrow  Alert me when this article is cited
space
 arrow  Add to Personal Archive
space
 arrow  Download to Citation Manager
space
 arrow  ACP Search                        
space
 arrow  Get Permissions
space
box Google Scholar
 arrow  Search for Related Content
space
box PubMed
Articles in PubMed by Author:
  arrow  McNagny, S. E.
space
 arrow  Related Articles in PubMed
space
 arrow  PubMed Citation
space
 arrow  PubMed
space

CLINICAL REVIEW

Prescribing Hormone Replacement Therapy for Menopausal Symptoms

right arrow Sally E. McNagny, MD, MPH

19 October 1999 | Volume 131 Issue 8 | Pages 605-616

This paper addresses the clinical presentation of menopause, pretreatment assessment for hormone replacement therapy, benefits and risks of this treatment, common hormone replacement regimens and their side effects, and patient management. The case-based discussion focuses on the clinical management of a patient who is considering hormone replacement therapy for menopausal symptoms.

Author and Article Information
space

From Emory University School of Medicine, Atlanta, Georgia.

Grant Support: In part by grant N01-WH-3211 from the National Heart, Lung, and Blood Institute (The Women's Health Initiative) and by an educational grant from Wyeth-Ayerst Laboratories.

Requests for Reprints: Sally E. McNagny, MD, MPH, Emory University School of Medicine, 69 Butler Street, Atlanta, GA 30303. For reprint orders in quantities exceeding 100, please contact the Reprints Coordinator; phone, 215-351-2657; e-mail, reprints{at}mail.acponline.org.




This article has been cited by other articles:


Home page
JNCI J Natl Cancer InstHome page
J. V. Lacey Jr., L. A. Brinton, M. F. Leitzmann, T. Mouw, A. Hollenbeck, A. Schatzkin, and P. Hartge
Menopausal hormone therapy and ovarian cancer risk in the National Institutes of Health-AARP Diet and Health Study Cohort.
J Natl Cancer Inst, October 4, 2006; 98(19): 1397 - 1405.
[Abstract] [Full Text] [PDF]


Home page
J Natl Cancer Inst MonogrHome page
C. L. Hartsfield, M. T. Connelly, K. M. Newton, S. E. Andrade, F. Wei, and D. S. M. Buist
Health System Responses to the Women's Health Initiative Findings on Estrogen and Progestin: Organizational Response
J Natl Cancer Inst Monographs, November 1, 2005; 2005(35): 113 - 115.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
M. J. Hepburn, D. P. Dooley, and M. J. Morris
The Effects of Estrogen Replacement Therapy on Airway Function in Postmenopausal, Asthmatic Women
Arch Intern Med, December 10, 2001; 161(22): 2717 - 2720.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
D. Altkorn and T. Vokes
Treatment of Postmenopausal Osteoporosis
JAMA, March 21, 2001; 285(11): 1415 - 1418.
[Full Text] [PDF]


Home page
Arch Intern MedHome page
J. A. Blakely
The Heart and Estrogen/Progestin Replacement Study Revisited: Hormone Replacement Therapy Produced Net Harm, Consistent With the Observational Data
Arch Intern Med, October 23, 2000; 160(19): 2897 - 2900.
[Abstract] [Full Text] [PDF]




 Home | Current Issue | Past Issues | In the Clinic | ACP Journal Club | CME | Collections | Audio/Video | Mobile | Subscribe | Tools | Help | ACP Online 

Copyright © 1999 by the American College of Physicians.